↓ Skip to main content

Cochrane Database of Systematic Reviews

Anticonvulsants for fibromyalgia

Overview of attention for article published in this source, October 2013
Altmetric Badge


87 Dimensions

Readers on

130 Mendeley
Anticonvulsants for fibromyalgia
Published by
John Wiley & Sons, Ltd, October 2013
DOI 10.1002/14651858.cd010782
Pubmed ID

Üçeyler, Nurcan, Sommer, Claudia, Walitt, Brian, Häuser, Winfried


Fibromyalgia (FM) is a clinically well-defined chronic condition of unknown aetiology characterised by chronic widespread pain that often co-exists with sleep problems and fatigue. People often report high disability levels and poor health-related quality of life (HRQoL). Drug therapy focuses on reducing key symptoms and disability, and improving HRQoL. Anticonvulsants (antiepileptic drugs) are drugs frequently used for the treatment of chronic pain syndromes.

Twitter Demographics

The data shown below were collected from the profiles of 20 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 130 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 <1%
Unknown 129 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 22 17%
Student > Bachelor 20 15%
Student > Doctoral Student 15 12%
Student > Ph. D. Student 14 11%
Student > Postgraduate 13 10%
Other 31 24%
Unknown 15 12%
Readers by discipline Count As %
Medicine and Dentistry 55 42%
Nursing and Health Professions 14 11%
Psychology 11 8%
Pharmacology, Toxicology and Pharmaceutical Science 8 6%
Neuroscience 4 3%
Other 18 14%
Unknown 20 15%